crescendobiologics.com Report : Visit Site

Technical data of the crescendobiologics.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host crescendobiologics.com. Currently, hosted in United Kingdom and its service provider is Fast Hosts Ltd .

the related websites

cherwell.gov.uk humangivenscollege.com yarnton-village.org.uk gov.uk wandptraining.co.uk qaa.ac.uk woodstock-tc.gov.uk ft.com ncpc.org.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx/1.12.2 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

careers contact in the news home about us overview management team board of directors investors humabody ® overview transgenic vh platform humabody ® therapeutics pipeline overview our proprietary pipeline our assets for partnering collaboration programmes partnering media press releases events press kit videos menu previous next 1 2 3 4 developing humabody ® therapeutics crescendo biologics appoints clinical development expert, dr igor matushansky, as non-executive director 2 july 2018 crescendo biologics appoints eva-lotta allan as non-executive director 18 june 2018 zai lab and crescendo biologics enter exclusive worldwide license agreement for innovative protein therapeutics for inflammatory indications 30 may 2018 crescendo biologics develops potent, multi-functional humabody ® therapeutics with a focus on novel targeted t-cell engagement. using our proprietary transgenic mouse platform, we have created a tumour-targeted t-cell engager mechanism capable of activating t-cells only in the tumour microenvironment. our ability to configure unique therapeutic formats allows humabodies to engage targets in ways that generates new biology through novel target engagement. our transgenic v h platform enables us to create an almost limitless number of mono- and multi-functional constructs capable of engaging therapeutically valuable targets in a way that is fundamentally different to whole antibodies. using our formatting and development expertise, we produce highly potent optimally configured therapeutics by using differentiated approaches such as: combinatorial specificity/functionality bi-paratopic targeting tuneable internalisation extended half-life. our unique tumour-targeted t-cell engagers deliver safe, highly potent cancer killing by activating only tumour-specific t-cells within the tumour microenvironment. their superior biodistribution through minimal size, enhanced tissue penetration and tumour accumulation has the potential to deliver greatly improved therapeutic index through both enhanced safety and potency. crescendo biologics appoints clinical development expert, dr igor matushansky, as non-executive director 2 july 2018 / in homepage , news / by carly king crescendo biologics appoints clinical development expert, dr igor matushansky, as non-executive director view pdf /wp-content/uploads/2016/02/logo_crescendo.png 0 0 carly king /wp-content/uploads/2016/02/logo_crescendo.png carly king 2018-07-02 09:04:37 2018-07-02 09:04:37 crescendo biologics appoints clinical development expert, dr igor matushansky, as non-executive director crescendo biologics appoints eva-lotta allan as non-executive director 18 june 2018 / in homepage , news , uncategorised / by carly king crescendo biologics appoints eva-lotta allan as non-executive director view pdf /wp-content/uploads/2016/02/logo_crescendo.png 0 0 carly king /wp-content/uploads/2016/02/logo_crescendo.png carly king 2018-06-18 10:13:35 2018-06-18 10:13:35 crescendo biologics appoints eva-lotta allan as non-executive director zai lab and crescendo biologics enter exclusive worldwide license agreement for innovative protein therapeutics for inflammatory indications 30 may 2018 / in homepage , news / by carly king zai lab and crescendo biologics enter exclusive worldwide license agreement for innovative protein therapeutics for inflammatory indications view pdf /wp-content/uploads/2016/02/logo_crescendo.png 0 0 carly king /wp-content/uploads/2016/02/logo_crescendo.png carly king 2018-05-30 12:30:35 2018-05-31 12:23:16 zai lab and crescendo biologics enter exclusive worldwide license agreement for innovative protein therapeutics for inflammatory indications see all news humabody ® products v h technology platform partnering patent-protected transgenic v h platform facilitates rapid assembly of optimally configured humabody ® therapeutics for novel biology. humabody ® is a registered trademark of crescendo biologics ltd. -- meditrina building 260, babraham research campus, cambridge, cb22 3at © 2016 crescendo biologics · privacy policy · website by instinctif partners scroll to top

URL analysis for crescendobiologics.com

http://www.crescendobiologics.com/about-us/
http://www.crescendobiologics.com/#prev
http://www.crescendobiologics.com/about-us/board-of-directors/
http://www.crescendobiologics.com/wp-content/uploads/2018/06/180613_crescendo-appoints-evalotta-draft_ip-clear-th-final.docx.pdf
http://www.crescendobiologics.com/media/press-kit/
http://www.crescendobiologics.com/about-us/contact/
http://www.crescendobiologics.com/#next-section
http://www.crescendobiologics.com/#next
http://www.crescendobiologics.com/media/videos/
http://www.crescendobiologics.com/privacy-policy
http://www.crescendobiologics.com/humabody/transgenic-vh-platform/
http://www.crescendobiologics.com/author/cking/
http://www.crescendobiologics.com/wp-content/uploads/2018/07/180621-crescendo-appoints-igor-final.pdf
http://www.crescendobiologics.com/about-us/careers/
http://www.crescendobiologics.com/category/homepage/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: CRESCENDOBIOLOGICS.COM
Registry Domain ID: 1546840755_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.1and1.com
Registrar URL: http://registrar.1and1.info
Updated Date: 2017-03-13T07:44:43Z
Creation Date: 2009-03-12T23:21:44Z
Registry Expiry Date: 2018-03-12T23:21:44Z
Registrar: 1&1 Internet SE
Registrar IANA ID: 83
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.6105601459
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS-UK.1AND1-DNS.BIZ
Name Server: NS-UK.1AND1-DNS.CO.UK
Name Server: NS-UK.1AND1-DNS.COM
Name Server: NS-UK.1AND1-DNS.ORG
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-07T05:09:47Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR 1&1 Internet SE

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =crescendobiologics.com

  PORT 43

  TYPE domain

DOMAIN

  NAME crescendobiologics.com

  CHANGED 2017-03-13

  CREATED 2009-03-12

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS-UK.1AND1-DNS.BIZ 217.160.81.3

  NS-UK.1AND1-DNS.CO.UK 217.160.80.3

  NS-UK.1AND1-DNS.COM 217.160.82.3

  NS-UK.1AND1-DNS.ORG 217.160.83.3

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .